Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01797224 · ClinicalTrials.gov registry record
OTIS Cimzia Pregnancy Registry
A clinical trial of Rheumatoid Arthritis and Psoriasis, sponsored by University of California, San Diego.
- Active
- Registry status
- 925
- Enrollment target
- 1
- Study location
NCT01797224 is a study of Rheumatoid Arthritis and Psoriasis that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 925 participants, below the 4,686-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01797224, a study of Rheumatoid Arthritis and Psoriasis, is active but no longer recruiting, sponsored by University of California, San Diego.
- ACTIVE NOT RECRUITING
- Registry status
- 925 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for five years after birth. With respect to fetal outcome, it is important to evaluate the spectrum of outcomes that may be relevant to a medication exposure during pregnancy, and these include both easily recognizable defects which are visible at birth, as well as more subtle or delayed defects that may not be readily identifiable without special expertise and observation beyond the newborn period.
Conditions Studied
Study Locations (1)
California
- University of California, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 925 participants |
| Start Date | 2012-03 |
| Est. Completion | 2026-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01797224
The ClinicalTrials.gov registry entry for NCT01797224 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 925 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,686-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (80% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT01797224 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01797224 about?
NCT01797224 is a clinical study titled "OTIS Cimzia Pregnancy Registry". The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for five years after birth. With respect to fetal outcome, i...
What is the current status of trial NCT01797224?
This trial is currently active not recruiting. The enrollment target is 925 participants. The study started on 2012-03. Estimated completion is 2026-03.
What conditions does trial NCT01797224 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Psoriasis, Crohn's Disease, Psoriatic Arthritis, Ankylosing Spondylitis.
Who is sponsoring clinical trial NCT01797224?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01797224 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.